As of January 1, 2017, LG Life Sciences, Ltd. was acquired by LG Chem, Ltd. LG Life Sciences, Ltd researches, develops, produces, and commercializes pharmaceuticals, animal health products, and specialty chemicals in South Korea and internationally. The company’s pharmaceutical products include fertility treatment related products; hormones; hyaluronic acid fillers; viscosupplements for the treatment of degenerative diseases; and chemicals, vaccines, contrast agents, veterinary medicines, and other HA products. It also provides crop protection products, such as insecticides, fungicides, herbicides, and pest management products; and pharmaceutical intermediates, including quinolone antibiotics, hyperlipidemia drugs, stomach ulcer treatments, and anticoagulants based on antifungal and antibiotic intermediates, as well as radiopaque contrast media, health supplements, and bulk pharmaceuticals. In addition, the company offers diagnostics products comprising ELISA kits; Real-time PCR kits; GenoBlot kits; and allergy screening systems, as well as active pharmaceutical ingredients, and healthcare information services. LG Life Sciences, Ltd is headquartered in Seoul, South Korea.